Works matching IS 03065251 AND DT 2017 AND VI 83 AND IP 11


Results: 28
    1
    2
    3
    4

    A call to incorporate systems theory and human factors into the existing investigation of harm in clinical research involving healthcare products.

    Published in:
    British Journal of Clinical Pharmacology, 2017, v. 83, n. 11, p. 2339, doi. 10.1111/bcp.13353
    By:
    • Edwards, Brian D.;
    • Bégaud, Bernard;
    • Daemen, Esther;
    • Dokas, Ioannis;
    • Fishbein, Jonathan M.;
    • Greenberg, Howard E.;
    • Hochberg, Alan;
    • Le Louet, Hervé;
    • Lyngvig, Jytte;
    • Mogles, Nataliya;
    • Owen, Kathryn;
    • Prendergast, Christine;
    • Rejzek, Martin;
    • Trantza, Sophia;
    • Webb, David J.;
    • Whalen, Matthew;
    • Whiteley, Simon
    Publication type:
    Article
    5
    6
    7
    8
    9

    Quantitative disease progression model of α-1 proteinase inhibitor therapy on computed tomography lung density in patients with α-1 antitrypsin deficiency.

    Published in:
    British Journal of Clinical Pharmacology, 2017, v. 83, n. 11, p. 2386, doi. 10.1111/bcp.13358
    By:
    • Tortorici, Michael A.;
    • Rogers, James A.;
    • Vit, Oliver;
    • Bexon, Martin;
    • Sandhaus, Robert A.;
    • Burdon, Jonathan;
    • Chorostowska‐Wynimko, Joanna;
    • Thompson, Philip;
    • Stocks, James;
    • McElvaney, Noel G.;
    • Chapman, Kenneth R.;
    • Edelman, Jonathan M.
    Publication type:
    Article
    10
    11

    Issue Information.

    Published in:
    British Journal of Clinical Pharmacology, 2017, v. 83, n. 11, p. 2333, doi. 10.1111/bcp.13115
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28